Tech Company Financing Transactions
ELIAS Animal Health Funding Round
Private investors participated in a $10 million Series A funding round for ELIAS Animal Health. The round was recorded on 4/10/2024.
Transaction Overview
Company Name
Announced On
4/10/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Funding will support the continued development of the company's product pipeline, which includes a novel oncolytic immunotherapy, a pilot study combining ECI® with a conditionally approved checkpoint inhibitor, and a pilot study evaluating its adoptive cell therapy in large breed dogs using a sophisticated surgical technique to avoid amputation.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
10900 Clay Blair Blvd 700
Olathe, KS 66061
USA
Olathe, KS 66061
USA
Phone
Undisclosed
Website
Email Address
Overview
Based in Olathe, Kan., ELIAS Animal Health is a medical biotechnology company advancing its novel therapies for the treatment of cancer in pets. The company's lead product candidate, the ELIAS cancer immunotherapy (ECI®), an autologous prescription product, is available to veterinarians under 9 CFR 103.3 as an experimental product. Efficacy and safety have not been established. The company's novel therapeutic approach offers the promise of improved clinical outcomes and the potential for fundamentally changing the way cancer is treated.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tammie Wahaus
Chief Medical Officer
Noe Reyes
Chief Operating Officer
Evan Courtemanche
Chief Scientific Officer
Gary Wood
VP - Sales
Brian Segebrecht
Browse more venture capital transactions:
Prev: 4/10/2024: TORL BioTherapeutics venture capital transaction
Next: 4/10/2024: Coherent venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs